Detalles de la búsqueda
1.
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
J Pediatr
; 231: 223-230, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340549
2.
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol
; 68(6): 1181-1190, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427729
3.
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Eur J Cancer
; 202: 114001, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489858
4.
Sequential analysis of cfDNA reveals clonal evolution in neuroblastoma patients receiving ALK targeted therapy.
Clin Cancer Res
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38787533
5.
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle.
Eur J Cancer
; 178: 49-59, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36403367
6.
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Trials
; 24(1): 298, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118818
7.
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.
JAMA Netw Open
; 6(7): e2321568, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399010
8.
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Cancer Discov
; 13(4): 858-879, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669143
9.
Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias.
Cancer Treat Rev
; 110: 102452, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998515
10.
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
J Exp Clin Cancer Res
; 41(1): 217, 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794623
11.
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
Eur J Cancer
; 158: 217-224, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34627664
12.
Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies.
Eur J Cancer
; 129: 71-79, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32143106
13.
The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.
Eur J Cancer
; 130: 39-50, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32172197
14.
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.
Lancet Haematol
; 6(1): e48-e57, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30528137
15.
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Trials
; 24(1): 452, 2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434205
16.
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.
Eur J Cancer
; 91: 21-29, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331748
17.
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.
Eur J Cancer
; 82: 34-44, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28646772
Resultados
1 -
17
de 17
1
Próxima >
>>